Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy

Background: Among patients with non-small cell lung cancer (NSCLC), we compared the progression-free survival (PFS) and proportion of acquisition of T790M mutation of the epidermal growth receptor gene (EGFR) after first-line treatment with epidermal growth factor receptor-tyrosine kinase inhibitors...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Diagnostics (Basel)
Egile Nagusiak: Inomata, Minehiko, Azechi, Kenji, Takata, Naoki, Hayashi, Kana, Tokui, Kotaro, Taka, Chihiro, Okazawa, Seisuke, Kambara, Kenta, Imanishi, Shingo, Miwa, Toshiro, Hayashi, Ryuji, Matsui, Shoko, Tobe, Kazuyuki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7759886/
https://ncbi.nlm.nih.gov/pubmed/33255696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics10121006
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak